- Case report
- Open Access
- Open Peer Review
A case of familial central precocious puberty caused by a novel mutation in the makorin RING finger protein 3 gene
BMC Endocrine Disorders volume 15, Article number: 60 (2015)
Central precocious puberty (CPP) is often familial but its genetic cause is largely unknown. Very recently, the makorin RING finger protein 3 (MKRN3) gene, located on chromosome 15 in the Prader-Willi syndrome (PWS)-associated region (15q11-q13), has been found mutated in 5 families with familial precocious puberty. The MKRN3 is a maternal imprinted gene and the phenotype is expressed only when the MKRN3 mutations are localized on the allele inherited from the father. The function of this gene is not completely known and the phenotype caused by its defect is not yet fully elucidated. We report a new MKRN3 mutation (Pro160Cysfs*14) causing familial CPP.
The index case is a 7 years old girl showing Tanner stage 3 and pubic hair stage 1. Her bone age evaluated by TW2 method was 10.3 years. Her hormonal data confirmed the diagnosis of central precocious puberty. Familial medical history revealed precocious puberty in a cousin on paternal side. Paternal grandmother had menarche at the age of 9 years and 6 months and premature menopause when she was 36 years old. Genetic analysis revealed a new mutation (c477_485del; Pro160Cysfs*14) in the maternally imprinted MKRN3. Puberty onset was at 5 years in the other affected female family member. Precocious puberty was well controlled by pharmacological therapy.
We expand the number of the MKRN3 mutations associated with CPP and highlight the importance of an accurate family medical history to disclose the peculiar pattern of inheritance of this gene.
Pubertal timing is influenced by complex interplay among genetic, nutritional, environmental and socioeconomic factors [1, 2]. Population-based studies have provided compelling evidence supporting genetic effects on pubertal timing .
Central precocious puberty (CPP) is defined by the gonadotropin-dependent development of secondary sexual characteristics before the age of 8 years in girls and 9 years in boys. CPP is familial in about 25 % of cases, showing an autosomal dominant transmission with incomplete, sex dependent, penetrance . Although recent genome-wide association studies have identified several loci associated with pubertal timing and age at menarche, the genetic causes of CPP are still largely unknown.
Mutations in the genes encoding kisspeptin I and its receptor represent the first identified genetic causes of CPP [5, 6]. Very recently, the makorin RING finger protein 3 (MKRN3) gene, located on chromosome 15 in the Prader-Willi syndrome (PWS)-associated region (15q11-q13), has been found mutated in 5 families with familial precocious puberty . MKRN3 is a maternal imprinted gene that is expressed only if transmitted from the father. Accordingly, MKRN3 mutations are not associated with pathological phenotype if transmitted from the mother .
The function of this gene is not completely known. Probably, it is involved in the ubiquitination of the proteins and its action leads to the inhibition of factors promoting the pubertal pulsatile GnRH secretion . Phenotype related to MKRN3 mutations has not been completely elucidated given the paucity of the report published after the first description [10–13].
We report a new mutation (Pro160Cysfs*14) in the maternally imprinted MKRN3 gene causing CPP in a girl and her cousin, and precocious menarche in her paternal grandmother.
A girl of Italian origin was examined at age of 7 years for premature thelarche. The thelarche appeared when the patient was 6 years old.
When the girl came to our observation, she showed breast Tanner stage 3 and pubic hair stage 1. Her bone age evaluated by TW2 method was 10 years and 3 months. Anthropometric parameters are shown in Table 1. Fifth fingers clinodactily of hands and lumbar hyperlordosis represented additional clinical signs.
Diagnosis of CPP was performed on the basis of hormonal data and pelvic ultrasound (Table 1). Thyroid hormones and adrenal steroids were normal. Brain Magnetic Resonance (MRI) did not disclose any abnormality both at hypothalamic and pituitary level. Treatment with Gonadotrophin‐releasing hormone agonists analog (GnRHa) was started (3.75 mg of the long-acting GnRHa depot triptorelin once a month, intramuscular route).
Maternal menarche age (12 years) and father pubertal development were normal, but we identified a 35 years old female cousin belonging to the paternal side who showed hormonal confirmed central precocious puberty (LH 3.9 IU/L, FSH 4.2 IU/L, Estradiol 35 pg/mL) and premature menarche when she was 7 years old (Fig. 1). Her parents had both normal puberty onset. Considering this medical history, we suspected a genetic cause for the CPP, and, therefore, we focused on MKRN3. The extended family was investigated. Assent was obtained from the children and informed consent was obtained from the adults involved in the study. The ethical committee of the Second University of Naples approved the study.
Genomic DNA was extracted from peripheral blood leukocytes. The encoding region of the intronless MKRN3 gene was amplified by overlapping primer pairs using standard PCR protocols, followed by direct sequencing of the purified PCR products.
We found a novel heterozygous mutation consisting in a deletion of 8 bp (c477_485del). It was a frameshift mutation and resulted in a premature stop codon leading to a truncated protein (Pro160Cysfs*14) with a predicted lack of both the C3HC4 RING motif and MKRN-specific Cys–His domain. Using the prediction models SIFT (Copyright 1993–2010, Fred Hutchinson Cancer Research Center, Seattle, WA, USA) and Provean (http://provean.jcvi.org), the P160Cfs*14 mutation has a deleterious effect consistent with the synthesis of a truncated and non-functional protein (score −13.5; threshold for deleterious effect: below −2.5). Both the proband and her cousin inherited the mutation from their fathers. In accordance with the expected pattern of inheritance, the fathers themselves reported to have normal puberty as they inherited the mutation from their mother (Fig. 1). Finally the grandmother reported precocious menarche (9 years and 6 months) and interestingly, premature menopause at 36 years. No clinical and biochemical data about the grandmother are available.
Currently, 13 different loss-of-function mutations of MKRN3 have been described in 30 patients with CPP from 17 multiplex families, including 7 frameshift defects, 4 missense mutations and 1 nonsense mutation [7, 10–13]. This kind of mutations, therefore, represent the most common cause of familial CPP.
We describe a family with CPP harboring a new mutation of the MKRN3 gene. The frameshift mutation we found was located in the amino-terminal region of the protein, codified by a rich poly C site. In this region other three mutations have been found, suggesting that this area can be a potential hot spot.
A variable onset of precocious puberty has been shown in the mutated subjects of the same family. The paternal side female cousin (III.1 in Fig. 1) and the grandmother (I.2 in Fig. 1) presented menarche when they were 7 and 9 years old respectively, while the proband (patient III.3) presented thelarche onset at the age of 6 years. In addition, the proband showed mild dysmorphisms (i.e.; clinodactily and hyperlordosis). Among the other three reported patients carrying MKRN3 loss of function mutations, one had clinodactily and hyperlordosis whereas the remaining two patients had esotropia [7, 11].
The mutated grandmother had also premature ovarian failure. This clinical feature has not been previously detected in patients with MKRN3 mutations. Although the association with premature ovarian failure is purely speculative at the moment, it is interesting to note that in in PWS patients gonadal failure has been described as part of the clinical spectrum . Of course, the link between the MKRN3 mutation and premature ovarian failure has to be confirmed studying large cohorts of adult mutated patients.
In our case the familial nature of the CPP was evident only by the presence of a second degree and a third degree relative affected from the paternal side, as parents were asymptomatic and the girl had no siblings. Our finding confirms a previous suspicion that the familial nature of CPP can be frequently under-recognized if not carefully investigated . Most children with CPP present for medical consultation accompanied by their mothers. Their paternal family history, therefore, may be often unknown, unavailable or under-investigated.
Due to maternal imprinting, only the paternal MKRN3 allele is expressed. CPP, therefore, can manifest only if the mutated MKRN3 allele comes from father. Nevertheless, fathers can be asymptomatic carriers if they have inherited the mutated allele form their mothers, as in our family. So we highlight the importance of an accurate family history that can unravel the familiar nature of CPP also in cases that seem sporadic. The determination of the precise onset of puberty in boys and in their fathers it is not simple since testicular enlargement is not as obvious as breast development and menarche in girls. So also when the father had precocious puberty, it could be not reported and only a very careful family medical history can reveal the presence of subjects with precocious puberty in second or third degree relatives.
Physicians should be aware of this kind of inheritance in CPP with the aim to promote MKRN3 genetic analysis, providing an additional tool for the diagnosis and adequate treatment of children with CPP.
The identification and the long-term follow-up of new patients with MKRN3 defects and CPP could be very interesting not only for the clarification of the phenotypes according with different kinds of mutations but also for establishing their risk of metabolic disorders and estrogen-dependent tumor development later in life.
Written informed consent was obtained from the parents for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Brain Magnetic Resonance
Central precocious puberty
Gonadotrophin‐releasing hormone agonists analog
- MKRN3 :
Makorin RING finger protein
Gajdos ZK, Hirschhorn JN, Palmert MR. What controls the timing of puberty? An update on progress from genetic investigation. Curr Opin Endocrinol Diabetes Obes. 2009;16:16–24.
Palmert MR, Boepple PA. Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab. 2001;86:2364–8.
Palmert MR, Hirschhorn JN. Genetic approaches to stature, pubertal timing, and other complex traits. Mol Genet Metab. 2003;80:1–10.
de Vries L, Kauschansky A, Shohat M, Phillip M. Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab. 2004;89:1794–800.
Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med. 2008;358:709–15.
Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, et al. Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab. 2010;95:2276–80.
Abreu AP, Dauber A, Macedo DB, Noel SD, Brito VN, Gill JC, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368:2467–75.
Butler MG. Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet. 2009;26:477–86.
Bohne A, Darras A, D’Cotta H, Baroiller JF, Galiana-Arnoux D, Volff JN. The vertebrate makorin ubiquitin ligase gene family has been shaped by large-scale duplication and retroposition from an ancestral gonad-specific, maternal-effect gene. BMC Genomics. 2010;11:721.
Settas N, Dacou-Voutetakis C, Karantza M, Kanaka-Gantenbein C, Chrousos GP, Voutetakis A. Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the MKRN3 gene. J Clin Endocrinol Metab. 2014;99:647–51.
Macedo DB, Abreu AP, Reis AC, Montenegro LR, Dauber A, Beneduzzi D, et al. Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3. J Clin Endocrinol Metab. 2014;99:1097–103.
Schreiner F, Gohlke B, Hamm M, Korsch E, Woelfle J. MKRN3 mutations in familial central precocious puberty. Horm Res Paediatr. 2014;82:122–6.
de Vries L, Gat-Yablonski G, Dror N, Singer A, Phillip M. A novel MKRN3 missense mutation causing familial precocious puberty. Hum Reprod. 2014;29:2838–43.
Gross-Tsur V, Hirsch HJ, Benarroch F, Eldar-Geva T. The FSH-inhibin axis in prader-willi syndrome: heterogeneity of gonadal dysfunction. Reprod Biol Endocrinol. 2012;10:39.
The authors declare that they have no competing interests.
AG designed the study, supervised the clinical assessment of patients and wrote the draft manuscript. GC and GC: conducted the genetic analysis, contributed to interpretation of the results and revised the manuscript. CL and PM: clinically followed patients and revised the manuscript. LP and EMG: contributed to design the study, to asses patients and revised the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Grandone, A., Cantelmi, G., Cirillo, G. et al. A case of familial central precocious puberty caused by a novel mutation in the makorin RING finger protein 3 gene. BMC Endocr Disord 15, 60 (2015). https://doi.org/10.1186/s12902-015-0056-8
- Precocious Puberty
- Pubertal Timing
- Premature Ovarian Failure
- Central Precocious Puberty
- Premature Menopause